SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (5571)3/20/2004 6:42:04 PM
From: Qualified Opinion  Respond to of 10345
 
Cacaito, it seems low but I'm in no position to disagree. The high estimate of potential peak sales revenue of Antegren for MS was forecasted by a European analyst per a Yahoo post. It would probably take several years to reach that level if ever. However, it's much lower than the hyped estimates on Yahoo and this board to prove a point. Prior to the early filing announcement, we read articles that indicated potential sales revenue of around $1 billion.

Rob



To: Cacaito who wrote (5571)3/20/2004 6:58:13 PM
From: Qualified Opinion  Read Replies (1) | Respond to of 10345
 
Cacaito, this is my last post on this Elan board unless the stock price corrects to my target buy price.

I can be contacted by the private message feature. My prediction is this forum will become very similar to Yahoo.

P.S. - Please don't make it necessary for me to respond publicly on this board.

Good luck to everyone,

Rob


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News